The services offered by the Spectroscopy Support Facility (SSF) cover two distinct areas: 1) applications of nuclear magnetic resonance (NMR), circular dichroism, and fluorescence spectroscopy for studies of biomolecular structure and function, and 2) magnetic resonance microscopy (MRM) for In vivo imaging of small animals especially relevant to cancer research. The Facility houses two well equipped NMR instruments, a 600 MHz (14 Tesla) magnet with a Bruker DMX-600 console, a wide-bore 300 MHz (7 Tesla) magnet with a Bruker DRX-300 console, including a Biospec microimaging accessory. Facility personnel maintain and operate the spectrometers, perform NMR analytical and small-animal imaging services, and offer expert advice and technical support to users. The 600 MHz instrument is fully equipped for heteronuclear multidimensional NMR studies on the structure, dynamics and interactions of biological macromolecules. The 300 MHz instrument is well suited for multinuclear analysis of small molecules and studies of enzyme function involving isotopically-labeled ligands. Small-animal imaging on the 300 MHz instrument is of interest to investigators studying mouse models of cancer. MRM permits monitoring of tumor development, growth, perfusion, vascularization, and response to treatment. New capabilities for optical imaging are being implemented in order to study tumors expressing luminescent or fluorescent proteins in small-animal models. The Spectroscopy Support Facility was rated """"""""Very Good to Excellent"""""""" at the last review. In 2003, the Facility was used by 18 peer-reviewed, funded investigators from 9 different Programs in all three Divisions. This represents an 80% increase over the number of users five years ago and addresses the previous concern that the Facility primarily served a small number of investigators in the Biomolecular Structure and Function Program. The broadened impact of the Facility is largely due to the implementation of small animal imaging, which made it possible to support cancer-related research Programs by eight additional users from all three Divisions. After the MR ilmaging services became fully operational, the usage of the 300 MHz instrument increased by two-fold. Over 99% of the total usage is by peer-reviewed, funded investigators. Data obtained with the help of the Facility have resulted in 27 publications in peer-reviewed journals over the past five years.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA006927-46
Application #
7651445
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2008-07-01
Budget End
2009-06-30
Support Year
46
Fiscal Year
2008
Total Cost
$268,321
Indirect Cost
Name
Fox Chase Cancer Center
Department
Type
DUNS #
073724262
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Sementino, Eleonora; Menges, Craig W; Kadariya, Yuwaraj et al. (2018) Inactivation of Tp53 and Pten drives rapid development of pleural and peritoneal malignant mesotheliomas. J Cell Physiol 233:8952-8961
Gupta, Sapna; Kelow, Simon; Wang, Liqun et al. (2018) Mouse modeling and structural analysis of the p.G307S mutation in human cystathionine ?-synthase (CBS) reveal effects on CBS activity but not stability. J Biol Chem 293:13921-13931
Peng, Hongzhuang; Prokop, Jeremy; Karar, Jayashree et al. (2018) Familial and Somatic BAP1 Mutations Inactivate ASXL1/2-Mediated Allosteric Regulation of BAP1 Deubiquitinase by Targeting Multiple Independent Domains. Cancer Res 78:1200-1213
Araiza-Olivera, Daniela; Chernoff, Jonathan (2018) Hras helps hippo heterodimerize to evade tumor suppression. Small GTPases 9:327-331
Shaikh, Talha; Handorf, Elizabeth A; Meyer, Joshua E et al. (2018) Mismatch Repair Deficiency Testing in Patients With Colorectal Cancer and Nonadherence to Testing Guidelines in Young Adults. JAMA Oncol 4:e173580
Reese, Jennifer Barsky; Smith, Katherine Clegg; Handorf, Elizabeth et al. (2018) A randomized pilot trial of a couple-based intervention addressing sexual concerns for breast cancer survivors. J Psychosoc Oncol :1-22
Auerbach, M V; Heckman, C J; Darlow, S (2018) To protect or not to protect: examining reasons for sun protection among young women at risk for skin cancer. J Behav Med 41:528-536
Roy, Anuradha (2018) Early Probe and Drug Discovery in Academia: A Minireview. High Throughput 7:
Ross, Kayleigh C; Chin, Kevin F; Kim, Daehwan et al. (2018) Methotrexate sensitizes drug-resistant metastatic melanoma cells to BRAF V600E inhibitors dabrafenib and encorafenib. Oncotarget 9:13324-13336
Diefenbach, Michael A; Benedict, Catherine; Miller, Suzanne M et al. (2018) Examining the impact of a multimedia intervention on treatment decision-making among newly diagnosed prostate cancer patients: results from a nationwide RCT. Transl Behav Med 8:876-886

Showing the most recent 10 out of 1280 publications